News
Stocktwits on MSN49m
BioNTech Gets Price Target Bumps From BofA, Clear Street After Strong Q2, Oncology Pipeline PushBioNTech is back in Wall Street’s spotlight after posting better-than-expected second-quarter results and doubling down on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback